President Trump has signed an executive order on prescription drug prices that walks back the "pill penalty" decried by PhRMA in President Biden's Inflation Reduction Act.

The proposed rule removes measures for health equity, vaccines for healthcare staff and the social drivers of health.

The decision was the latest chapter in ongoing litigation between Humana and CMS over the validity of its star ratings. Jeff Lagasse, Editor Healthcare lease accounting insights: How two organizations ...

House GOP members are demanding cuts of at least $1.5 billion in federal spending, but Senate Republicans are divided. A complete guide to lease accounting for healthcare organizations Making a ...